HomeGERN • NASDAQ
add
Geron Corp
Previous close
$1.32
Day range
$1.27 - $1.33
Year range
$1.09 - $4.83
Market cap
810.28M USD
Avg Volume
9.05M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 49.04M | 5,459.64% |
Operating expense | 38.56M | -2.17% |
Net income | -16.38M | 75.70% |
Net profit margin | -33.39 | 99.56% |
Earnings per share | -0.02 | 80.00% |
EBITDA | -12.33M | 82.15% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 387.98M | 6.96% |
Total assets | 555.20M | 23.54% |
Total liabilities | 295.67M | 107.19% |
Total equity | 259.53M | — |
Shares outstanding | 638.02M | — |
Price to book | 3.22 | — |
Return on assets | -5.57% | — |
Return on capital | -8.07% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -16.38M | 75.70% |
Cash from operations | -27.42M | 48.74% |
Cash from investing | 20.32M | 156.20% |
Cash from financing | 1.09M | -93.52% |
Net change in cash | -6.01M | 91.75% |
Free cash flow | -23.41M | 19.26% |
About
Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase. Wikipedia
Founded
1990
Headquarters
Website
Employees
229
